IDEAYA Biosciences (IDYA) Return on Sales (2020 - 2026)

IDEAYA Biosciences has disclosed Return on Sales across 7 years of filings, most recently posting 0.17% for Q1 2026.

• Return on Sales for Q1 2026 came in at 0.17%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 0.01% (changed N/A YoY), and the FY2025 annual result was 0.01%, up 46.0% from the prior year.
• Return on Sales came in at 0.17% for Q1 2026 at IDEAYA Biosciences, down from 0.09% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.01% in Q3 2025 to a low of 0.57% in Q3 2024.
• The 5-year median for Return on Sales is 0.09% (2025), against an average of 0.11%.
• Across the five-year window, Return on Sales slumped 53 bps in 2024 and soared 58 bps in 2025, its largest moves.
• IDEAYA Biosciences' Return on Sales stood at 0.07% in 2022, then tumbled by 63 bps to 0.11% in 2023, then sank by 93 bps to 0.21% in 2024, then soared by 58 bps to 0.09% in 2025, then slumped by 90 bps to 0.17% in 2026.
• The last three Return on Sales figures came in at 0.17% (Q1 2026), 0.09% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.